Recently, we demonstrated that thioridazine dramatically suppressed cell growth by inducing apoptosis, and that its angiostatic effects were mediated by the inhibition of FAK/mTOR signaling in ovarian cancer cells in vitro [6, 7]. This evidence concerns the gene PTK2 and ovarian cancer.